產(chǎn)品編號(hào) | Ys-0356R |
英文名稱 | Digoxin |
中文名稱 | 地高辛抗體 |
別 名 | Digoxigenin; Lanoxin. |
產(chǎn)品類型 | 小分子抗體 |
研究領(lǐng)域 | 細(xì)胞生物 免疫學(xué) 藥物及化合物 |
抗體來源 | Rabbit |
克隆類型 | Polyclonal |
產(chǎn)品應(yīng)用 | ELISA=1:5000-10000 not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
理論分子量 | 0.78kDa |
性 狀 | Liquid |
濃 度 | 1mg/ml |
免 疫 原 | BSA conjugated Digoxin |
亞 型 | IgG |
純化方法 | affinity purified by Protein A |
緩 沖 液 | 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
保存條件 | Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. |
注意事項(xiàng) | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
PubMed | PubMed |
產(chǎn)品介紹 | Digoxin is a beta blocker drug originally derived from the foxglove plant, Digitalis lanata. Digoxin is used primarily to improve the pumping ability of the heart in congestive heart failure (CHF), and treat problems such as high blood pressure. It is also used to help normalize some dysrhythmias (abnormal types of heartbeat). SWISS: N/A CAS: 20830-75-5 1.用于治療充血性心力衰竭,對(duì)于高血壓、瓣膜病、先天性心臟病所引起的充血性心力衰竭療效良好。對(duì)繼發(fā)于嚴(yán)重貧血、甲狀腺功能低下及維生素Bl缺乏癥的充血性心力衰竭則治療效果差;對(duì)于肺源性心臟病、心肌嚴(yán)重缺血或活動(dòng)性心肌炎及心肌外機(jī)械因素所致心力衰竭療效也差。 2.用于控制快速性心房顫動(dòng)、心房撲動(dòng)的心室率。 |
我要詢價(jià)
*聯(lián)系方式:
(可以是QQ、MSN、電子郵箱、電話等,您的聯(lián)系方式不會(huì)被公開)
*內(nèi)容: